AstraZeneca's Kendall Square R&D center in Cambridge, MA. (Credit: Pickard Chilton)
AstraZeneca budgets another $2B to boost manufacturing and R&D in US
Among a flurry of third-quarter updates on Tuesday, AstraZeneca said it is earmarking an additional $2 billion to add 1,000 new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
